Journal of Applied Physiology, Vol 71, Issue 5 2026-2031, Copyright © 1991 by American Physiological Society

ARTICLES

N omega-nitro-L-arginine methyl ester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin

T. J. McMahon, J. S. Hood, J. A. Bellan and P. J. Kadowitz
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

The effects of N omega-nitro-L-arginine methyl ester (L-NAME), an inhibitor of endothelium-derived relaxing factor (EDRF) production, on vascular tone and responses were investigated in the pulmonary vascular bed of the intact-chest cat under conditions of controlled blood flow and constant left atrial pressure. When pulmonary vascular tone was elevated with U-46619, intralobar injections of acetylcholine, bradykinin, sodium nitroprusside, isoproterenol, prostaglandin E1 (PGE1), lemakalim, and 8-bromo-guanosine 3',5'-cyclic monophosphate (8-bromo-cGMP) dilated the pulmonary vascular bed. Intravenous administration of L-NAME elevated lobar arterial and systemic arterial pressures without altering left atrial pressure. When U-46619 was infused after L-NAME to raise lobar arterial pressure to levels similar to those attained during the control period, vasodilator responses to acetylcholine and bradykinin were reduced significantly, whereas responses to PGE1, lemakalim, and 8-bromo-cGMP were not altered, and responses to nitroprusside were increased. There was a small effect on the response to the highest dose of isoproterenol, and pressor responses to BAY K 8644 and angiotensin II were not altered. These results are consistent with the hypothesis that EDRF production may involve the formation of nitric oxide or a nitroso compound from L-arginine and that EDRF production may have a role in the regulation of tone and in the mediation of responses to acetylcholine and bradykinin in the pulmonary vascular bed of the cat.

This article has been cited by other articles:

				J. B. Gordon, M. A. VanderHeyden, T. R. Halla, E. P. Cortez, G. Hernandez, S. T. Haworth, C. A. Dawson, and J. A. Madden What leads to different mediators of alkalosis-induced vasodilation in isolated and in situ pulmonary vessels? Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L799 - L807. [Abstract] [Full Text] [PDF]

				A. L. Hyman, B. J. De Witt, B. Gumusel, Q. Hao, P. J. Kadowitz, and H. L. Lippton L-NAME enhances responses to atrial natriuretic peptide in the pulmonary vascular bed of the cat J Appl Physiol, June 1, 2001; 90(6): 2101 - 2108. [Abstract] [Full Text] [PDF]

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				A. L. Hyman, Q. Hao, A. Tower, P. J. Kadowitz, H. C. Champion, B. Gumusel, and H. Lippton Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1218 - H1229. [Abstract] [Full Text] [PDF]

				E. M. Wagner Effects of edema on small airway narrowing J Appl Physiol, September 1, 1997; 83(3): 784 - 791. [Abstract] [Full Text] [PDF]

				W. Steudel, F. Ichinose, P. L. Huang, W. E. Hurford, R. C. Jones, J. A. Bevan, M. C. Fishman, and W. M. Zapol Pulmonary Vasoconstriction and Hypertension in Mice With Targeted Disruption of the Endothelial Nitric Oxide Synthase (NOS 3) Gene Circ. Res., July 19, 1997; 81(1): 34 - 41. [Abstract] [Full Text]

				R. Haberberger, M. Schemann, H. Sann, and W. Kummer Innervation pattern of guinea pig pulmonary vasculature depends on vascular diameter J Appl Physiol, February 1, 1997; 82(2): 426 - 434. [Abstract] [Full Text] [PDF]

				C. J. Cooper, M. J. Landzberg, T. J. Anderson, F. Charbonneau, M. A. Creager, P. Ganz, and A. P. Selwyn Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in Humans Circulation, January 15, 1996; 93(2): 266 - 271. [Abstract] [Full Text]